...
首页> 外文期刊>The biochemical journal >Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis
【24h】

Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis

机译:Oct-1在人内皮细胞中的凝集素样氧化型低密度脂蛋白受体-1(LOX-1)转录调控:对动脉粥样硬化的影响

获取原文
           

摘要

pLOX-1, a receptor for ox-LDL (oxidized low-density lipoprotein), has recently been determined to play a critical role in the progression of atherosclerosis. LOX-1 expression (mRNA and protein) has been shown to be up-regulated by pro-atherogenic stimuli, such as ox-LDL and Ang II (angiotensin II). However, the molecular mechanisms of these up-regulations are unclear. In the present study, we explored LOX-1 transcriptional promoter activation in response to ox-LDL and Ang II. Under basal states, LOX-1 core promoter (LOX-1 ?35/+36) was found to be sufficient for its basal activity in HCAECs (human coronary artery endothelial cells). More importantly, we found that ox-LDL (60 μg/ml for 24 h) induced LOX-1 promoter activity significantly and that a 105 bp fragment (between nt ?1599 and ?1494) was required for this activation. Within this 106 bp fragment, there is a potential binding motif for the transcription factor Oct-1 (octamer-1). By electrophoretic mobility-shift assay, we observed the activation of Oct-1 by ox-LDL. The critical role of Oct-1 in ox-LDL-induced LOX-1 promoter activation was further confirmed by mutagenesis assay. For comparison, we also examined LOX-1 promoter activation in response to Ang II (1 μmol/l for 24 h). Interestingly, another promoter region, between nt ?2336 and ?1990, was required for Ang II-induced LOX-1 promoter activation. In conclusion, the present study strongly suggests that ox-LDL, by activating Oct-1, induces LOX-1 promoter activation. Furthermore, this study suggests that while ox-LDL and Ang II both induce LOX-1 expression in HCAECs, the underlying mechanisms of promoter activation are different from each other./p
机译:ox-LDL(氧化的低密度脂蛋白)受体LOX-1最近被确定在动脉粥样硬化的进展中起关键作用。已经显示LOX-1表达(mRNA和蛋白质)被促动脉粥样硬化刺激(例如ox-LDL和Ang II(血管紧张素II))上调。但是,这些上调的分子机制尚不清楚。在本研究中,我们探索了响应ox-LDL和Ang II的LOX-1转录启动子激活。在基础状态下,发现LOX-1核心启动子(LOX-1α35/ + 36)足以在HCAEC(人冠状动脉内皮细胞)中发挥其基础活性。更重要的是,我们发现ox-LDL(24 h的浓度为60μg/ ml)显着诱导了LOX-1启动子的活性,并且该激活需要105 bp的片段(在nt 1599和nt 1494之间)。在这个106 bp的片段中,存在转录因子Oct-1(octamer-1)的潜在结合基序。通过电泳迁移率变动分析,我们观察到ox-1 LDL对Oct-1的激活。诱变分析进一步证实了Oct-1在ox-LDL诱导的LOX-1启动子激活中的关键作用。为了进行比较,我们还检查了响应于Ang II(1μmol/ l,持续24h)的LOX-1启动子激活。有趣的是,Ang II诱导的LOX-1启动子激活需要另一个在nt 2336和1990之间的启动子区域。总之,本研究强烈建议通过激活Oct-1,ox-LDL可以诱导LOX-1启动子激活。此外,这项研究表明,虽然ox-LDL和Ang II均可诱导HCAECs中LOX-1的表达,但启动子激活的潜在机制彼此不同。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号